The mechanism by which<unk>  might be effective in ALS is unknown. The drug is known to be an antioxidant, and oxidative stress has been hypothesized to be part of the process that kills neurons in people with ALS. The half-life of<unk>  is 4.5 to 6 hours and the half-lives of its metabolites are 2 to 3 hours. It is metabolized to a sulfate conjugate and a glucuronide conjugate, neither of which are active. It is primarily excreted in urine as the glucuronide conjugate form.
Edaravone
Molindone
Delavirdine
Nintedanib
Ablomin
Vatalanib
Bexarotene
Triazoledione